蒲地蓝消炎口服液临床应用专家共识

Expert consensus statement on Pudilan Xiaoyan Oral Liquid in clinical practice

蒲地蓝消炎口服液的功效长于清热解毒,利咽消肿,适用于热毒壅盛证引起的咽喉肿痛,功效在于缓解肿痛(红肿热痛),是2015年版《中国药典》收录品种,目前已进入陕西、江苏、辽宁、湖南、天津、新疆、河北等地的省级医保;先后被北京、重庆等省市卫生部门推荐作为预防和治疗甲流、手足口病的首选用药之一,并被卫生部列入《手足口病诊疗指南》,以及被中华中医药学会肺系病分会主编《中成药临床应用指南》、中华中医药学会《中医药单用/联合抗生素治疗常见感染性疾病临床实践指南》等推荐。为进一步提高临床医生对该药的认识,更好地指导其临床合理用药,特邀请来自中西医呼吸科、感染科、皮肤科等领域的临床一线专家研制编撰该专家共识。该共识充分考虑临床证据和专家临床经验,通过名义组法,对于有证据支持的临床问题形成推荐意见,对于没有证据支持的临床问题形成共识建议。该共识基于临床研究证据和专家经验,采用简洁明了的体例格式,为该药的临床使用提供了初步的参照。

Pudilan Xiaoyan Oral Liquid has effects in clearing away heat and detoxifying,and is used to treat pharynx and throat swelling caused by the syndrome of excessive heat and toxin accumulation. Its efficacy is to relieve swelling and pain( redness,swelling and hot pain). It is included in the Chinese Pharmacopoeia of 2015 Edition,and has been listed in provincial health insurance directories of Shaanxi,Jiangsu,Liaoning,Hunan,Tianjin,Xinjiang and Hebei. It has been recommended by health departments of Beijing,Chongqing and other provinces as a preferred drug for the prevention and treatment of H1 N1 and HFMD,and listed in the diagnosis and Treatment Guide of HFMD by the Ministry of Health,the Clinical Application Guide of Chinese Patent Medicine edited by the Lung Department Disease Branch of China Association of Chinese Medicine,and the Clinical Practice Guide of Single Administration/Combined Administration of Antibiotics in Treatment of Common Infectious Diseases by China Association of Chinese Medicine. To further improve the clinician’s understanding of drugs and better guide the rational clinical application,we invited front-line clinical experts from respiratory department,infectious department and dermatology of traditional Chinese and Western medicine to develop and compile the expert consensus. The consensus fully considered the clinical evidence and the expert clinical experience to give recommendations for clinical problems with evidence support and consensus suggestions for clinical problems without evidence support by the nominal group method.This consensus is based on clinical research evidence and expert experience in a simple and clear format,which provides a preliminary reference for the clinical use of the drug.